CONTACT US
Introduced in 2017, the Precision Medicine Targeted Grants are intended to fund high-priority projects that utilize patients’ tumors’ molecular characteristics to help determine the best treatment options.
In 2017, two Precision Medicine Targeted Grants were awarded, and the recipients received extensions in 2021. Click below to learn about these grantees and their funded projects.
2017 Skip Viragh Pancreatic Cancer Action Network Precision Medicine Targeted Grant
Gregory Beatty, MD, PhD
2021 Pancreatic Cancer Action Network Precision Medicine Targeted Grant Extension in memory of Skip Viragh
University of Pennsylvania
Multiplex Tissue-based Assays and Analytical Tools for Pancreatic Cancer
2017 1440 Foundation Pancreatic Cancer Action Network Precision Medicine Targeted Grant
Sunil R. Hingorani, MD, PhD
2021 Pancreatic Cancer Action Network Precision Medicine Targeted Grant Extension funded by Cheryl and Steve Kole, and Rudy Revak
Fred Hutchinson Cancer Research Center
Combining Stromal Disruption and Relief of Immune Suppression to Treat PDA
